The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer

por Gravgaard, KH, Lyng, MB, Laenkholm, A-V, Søkilde, R, Nielsen, BS, Litman, T, Ditzel, HJ
Publicado 2011

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients

por Hansen, S, Overgaard, J, Rose, C, Knoop, Ann, Lænkholm, A-V, Andersen, J, Sørensen, F B, Andreasen, P A
Publicado 2003

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

por Elias, D., Vever, H., Lænkholm, A.-V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., Ditzel, H. J.
Publicado 2019

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.

por Knoop, A., Andreasen, P. A., Andersen, J. A., Hansen, S., Laenkholm, A. V., Simonsen, A. C., Andersen, J., Overgaard, J., Rose, C.
Publicado 1998

Rates of re‐excision and conversion to mastectomy after breast‐conserving surgery with or without oncoplastic surgery: a nationwide population‐based study

por Heeg, E., Jensen, M. B., Hölmich, L. R., Bodilsen, A., Tollenaar, R. A. E. M., Lænkholm, A. V., Offersen, B. V., Ejlertsen, B., Mureau, M. A. M., Christiansen, P. M.
Publicado 2020